DexCom, Inc. (DXCM)
Listed on NASDAQ • Healthcare / Medical - Devices
Overview
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Explore More Data
Key Information
Symbol:
DXCM
CEO:
Kevin Ronald Sayer
Exchange:
NASDAQ
CIK:
0001093557
Website:
https://www.dexcom.com
SEC Filings:
View SEC →
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Price
59.28
Change
-1.9
Change %
-3.11%
Open
60.95
Previous Close
61.18
High
60.95
Low
58.34
Volume
8,834,666
Market Cap
23,120,162,816
EV/EBITDA
29.65
Capital Structure (Updated: Nov 05 04:00 PM EST)
Shares Outstanding
390,016,272
FloatShares
387,383,662
Float Ratio
99.32%
Shares Short
11,617,322
Short Percent Of Float
The percent of float shares currently sold short. Reflects market sentiment and risk of a short squeeze.
3.82%
Short Ratio
Days needed to cover all short positions. Indicates short-selling pressure.
1.84 trading days
Held Percent Insiders
0.41%
Held Percent Institutions
97.04%
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-10-30 |
| Earnings Call | 2025-10-30 |
| Avg EPS Estimate | 0.6473 |
| Low EPS Estimate | 0.59 |
| High EPS Estimate | 0.69 |
| Revenue | |
| Avg Revenue Forecast | 1,242,096,050 |
| Low Revenue Forecast | 1,232,000,000 |
| High Revenue Forecast | 1,250,154,430 |
DXCM Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $3,322,099,968 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 1.346 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 1.565 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $2,575,600,128 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
DXCM Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $1,022,099,968 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $1,448,099,968 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $783,387,520 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 59.01% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 20.05% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | 15.96% | Net profit margin, which reflects overall profitability. |
DXCM Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 94.48% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $2,575,600,128 | Used together with cash and EBITDA to assess debt-paying ability. |
DXCM Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | 21.60% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | 109.90% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for DXCM (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $59.28 | Latest stock trading price |
| Price Target (High) | $115 | Analyst highest expected price |
| Price Target (Low) | $75 | Analyst lowest expected price |
| Price Target (Average) | $87 | Average target price across analysts |
| Price Target (Median) | $84 | Median of target prices |
| Average Rating Score | 1.43 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | strong_buy | Consensus rating |
| Analyst Coverage Count | 25 | Number of analysts providing estimates |
| Cash Holdings | $3,322,099,968 | Total cash held by the company |
| Cash per Share | $8.52 | Cash value per outstanding share |
| Total Debt | $2,575,600,128 | Company's total debt |
| Quick Ratio | 1.346 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 1.565 | Overall short-term liquidity |
| Debt/Equity Ratio | 94.48% | Leverage ratio: Debt / Equity |
| EBITDA | $1,022,099,968 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $4,515,899,904 | Total company revenue |
| Revenue per Share | $11.544 | Total revenue divided by shares outstanding |
| Gross Profit | 59.01% | Revenue minus cost of goods sold |
| Return on Assets | 7.02% | Net income / Total assets |
| Return on Equity | 30.64% | Net income / Shareholder equity |
| Earnings Growth (YoY) | 109.90% | Year-over-year EPS growth |
| Revenue Growth (YoY) | 21.60% | Year-over-year revenue growth |
| Gross Margin | 59.01% | Gross profit / Total revenue |
| EBITDA Margin | 22.63% | EBITDA / Revenue |
| Operating Margin | 20.05% | Operating income / Revenue |
| Profit Margin | 15.96% | Net income / Revenue |
| Free Cash Flow | $783,387,520 | Cash left after capital expenditures |
| Operating Cash Flow | $1,448,099,968 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |